PetVivo CEO John Lai on Disrupting Pet Health with Spryng & Precise PRP

PetVivo's Flagship Product: Spryng with OsteoCushion Technology

• 💡 Spryng with OsteoCushion Technology is a naturally derived veterinary medical device designed to restore joint mechanics by functioning as an extracellular matrix.
• 🎯 It addresses the root cause of osteoarthritis, unlike NSAIDs and steroids which only mask pain and can worsen cartilage degradation.
• 🔑 Provides up to 12 months of relief and integrates naturally into the synovium, requiring no FDA animal-side studies due to its human medical device designation.
• 🚀 Over 12,000 animals have been treated with Spryng, with hundreds of documented case studies showing significant improvements.

Precise PRP: A Revolutionary Platelet-Rich Plasma Solution

• ✨ Precise PRP is the only PRP product reviewed by the FDA for safety, offering significant advantages over traditional methods.
• ⏱️ It requires no centrifuge or blood draw, saving veterinarians 30+ minutes per procedure.
• 📈 Guarantees a high platelet count of 4 million platelets per dose, ensuring consistent regenerative results.
• ✅ The product is conveniently off-the-shelf and ready for injection.

Market Expansion and Strategic Partnerships

• 🌍 PetVivo has expanded its distribution to Mexico and the UK, with the rest of the EU anticipated within 6-9 months.
• 🤝 The company has partnered with Veterinary Growth Partners (7,300 clinics) to accelerate national adoption.
• 📈 Distributed by five of the largest vet distributors, including MWI, Covetrus, Vetco, Patterson, and Clipper.
• 🐎 Spryng is the only product allowed by HISA (Horse Integrity and Safety Authority) without triggering racing bans for hydrogel injections.

Innovation and Future Growth

• 🤖 A new AI platform utilizing agentic swarming technology is launching within 30 days to help clinics increase margins and reduce customer acquisition costs by 90%.
• 🏥 PetVivo is preparing for human clinical studies targeting the $11 billion US joint replacement market, aiming to delay or prevent surgeries.
• 🔬 The company possesses a strong IP portfolio with 12 U.S. patents and 19 foreign patents.
• 💰 The U.S. pet care market is projected to grow, with veterinary care and products being the leading drivers, indicating strong market tailwinds.